Exbio — Research products — Antibodies — Cytoskeleton and ECM — Anti-Cytokeratin 10/13 Purified

Anti-Cytokeratin 10/13 Purified

Regulatory status

RUO

Antigen

Cytokeratin 10/13

Clone

DE-K13

Format

Purified

Reactivity

Cat, Human

Application

WB, IHC(F), IHC(P)

Variant

0.1 mg

11-478-C100

In stock

143.00 USD

0.025 mg

11-478-C025

Delivery 1 week

71.50 USD

Variant

0.1 mg

11-478-C100

In stock

143.00 USD

0.025 mg

11-478-C025

Delivery 1 week

71.50 USD

Contact distributor

Product details

Description

Images

References

SDS download

Isotype

Mouse IgG2a

Specificity

The mouse monoclonal antibody DE-K13 reacts with cytokeratin 10 (56.5 kDa) and cytokeratin 13 (53 kDa). Cytokeratins are members of intermediate filaments subfamily of intracellular proteins, represented in epithelial tissues. DE-K13 recognizes only cytokeratin 13 on formalin-fixed, paraffin-embedded tissue sections.

Application

WB, IHC(F), IHC(P)

Application details

Immunohistochemistry (paraffin sections): Standard ABC technique (DAB+), recommended dilution: 10 μg/ml (1:100), positive tissue: tonsil. Pretreatment: 0.1% pepsin in 0.1 M HCl for 30 min at room temperature or Target Retrieval Solution - High pH. The antibody DE-K13 reacts exclusively with Cytokeratin 13.
Immunohistochemistry (frozen sections): Use at an assay dependent dilution.
Western blotting: recommended dilution: 1-3 μg/ml.

Reactivity

Cat, Human

Immunogen

Cytoskeletal preparation extracted from human ectocervical epithelium.

Concentration

1 mg/ml

Preparation

Purified by protein-A affinity chromatography.

Formulation

Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide

Storage and handling

Store at 2-8°C. Do not freeze.

The product is intended For Research Use Only. Diagnostic or therapeutic applications are strictly forbidden. Products shall not be used for resale or transfer to third parties either as a stand-alone product or as a manufacture component of another product without written consent of EXBIO Praha, a.s. EXBIO Praha, a.s. will not be held responsible for patent infringement or any other violations of intellectual property rights that may occur with the use of the products. Orders for all products are accepted subject to the Term and Conditions available at www.exbio.cz. EXBIO, EXBIO Logo, and all other trademarks are property of EXBIO Praha, a.s.

Other names

K10, K13, CK10, CK13, CK-10, CD13, CYK10, CYK13, KRT10, KRT13

Antigen description

Cytokeratins are a subfamily of intermediate filaments and are characterized by remarkable biochemical diversity. They are represented in epithelial tissues by at least 20 different polypeptides, molecular weight between 40 kDa and 68 kDa. The individual cytokeratin polypeptides are designated 1 to 20 and divided into the type I (acidic cytokeratins 9-20) and type II (basic to neutral cytokeratins 1-8) families. Cytokeratins 10 and 13 both belong to type I family (acidic cytokeratins).

Immunohistochemistry staining of tonsil (paraffin-embedded sections) with anti-Cytokeratin 10+13, (DE-K13). The antibody DE-K13 stains only Cytokeratin 13 when used on formalin-fixed, paraffin-embedded tissue sections.

Product specific references:

Ivanyi D, Minke JM, Hageman C, Groeneveld E, van Doornewaard G, Misdorp W: Cytokeratins as markers of initial stages of squamous metaplasia in feline mammary carcinomas. Am J Vet Res. 1993 Jul;54(7):1095-102.
PubMed

Ivanyi D, Minke JM, Hageman C, Groeneveld E, van Doornewaard G: Patterns of expression of feline cytokeratins in healthy epithelia and mammary carcinoma cells. Am J Vet Res. 1992 Mar;53(3):304-14.
PubMed

Kozaki M, Nakamura Y, Iguchi M, Kano R, Watanabe S, Fujiwara K, Hasegawa A: Immunohistochemical analysis of cytokeratin expression in dog skin. J Vet Med Sci. 2001 Jan;63(1):1-4.
PubMed